These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25947006)

  • 41. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development.
    Luchtefeld M; Grothusen C; Gagalick A; Jagavelu K; Schuett H; Tietge UJ; Pabst O; Grote K; Drexler H; Förster R; Schieffer B
    Circulation; 2010 Oct; 122(16):1621-8. PubMed ID: 20921438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD8
    Schäfer S; Zernecke A
    Cells; 2020 Dec; 10(1):. PubMed ID: 33383733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dendritic cells in atherosclerotic disease.
    Niessner A; Weyand CM
    Clin Immunol; 2010 Jan; 134(1):25-32. PubMed ID: 19520615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity.
    Hilgendorf I; Theurl I; Gerhardt LM; Robbins CS; Weber GF; Gonen A; Iwamoto Y; Degousee N; Holderried TA; Winter C; Zirlik A; Lin HY; Sukhova GK; Butany J; Rubin BB; Witztum JL; Libby P; Nahrendorf M; Weissleder R; Swirski FK
    Circulation; 2014 Apr; 129(16):1677-87. PubMed ID: 24488984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophages and Their Contribution to the Development of Atherosclerosis.
    Bobryshev YV; Nikiforov NG; Elizova NV; Orekhov AN
    Results Probl Cell Differ; 2017; 62():273-298. PubMed ID: 28455713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophages in vascular inflammation and atherosclerosis.
    Cochain C; Zernecke A
    Pflugers Arch; 2017 Apr; 469(3-4):485-499. PubMed ID: 28168325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidized low-density lipoprotein-induced apoptotic dendritic cells as a novel therapy for atherosclerosis.
    Frodermann V; van Puijvelde GH; Wierts L; Lagraauw HM; Foks AC; van Santbrink PJ; Bot I; Kuiper J; de Jager SC
    J Immunol; 2015 Mar; 194(5):2208-18. PubMed ID: 25653425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Notch Signaling Regulates Immune Responses in Atherosclerosis.
    Vieceli Dalla Sega F; Fortini F; Aquila G; Campo G; Vaccarezza M; Rizzo P
    Front Immunol; 2019; 10():1130. PubMed ID: 31191522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophage phenotypes in atherosclerosis.
    Colin S; Chinetti-Gbaguidi G; Staels B
    Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability.
    Schrijvers DM; De Meyer GR; Herman AG; Martinet W
    Cardiovasc Res; 2007 Feb; 73(3):470-80. PubMed ID: 17084825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammation and immune system interactions in atherosclerosis.
    Legein B; Temmerman L; Biessen EA; Lutgens E
    Cell Mol Life Sci; 2013 Oct; 70(20):3847-69. PubMed ID: 23430000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen-presenting dendritic cells in atherosclerosis.
    Gil-Pulido J; Zernecke A
    Eur J Pharmacol; 2017 Dec; 816():25-31. PubMed ID: 28822856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function.
    Han X; Boisvert WA
    Thromb Haemost; 2015 Mar; 113(3):505-12. PubMed ID: 25373619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of inflammatory dendritic cells in innate and adaptive immunity.
    Hespel C; Moser M
    Eur J Immunol; 2012 Oct; 42(10):2535-43. PubMed ID: 23042650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immune cells in atherosclerosis--good or bad?].
    Klingenberg R; Matter CM; Lüscher TF
    Praxis (Bern 1994); 2016 Apr; 105(8):437-44. PubMed ID: 27078727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD137-inducing factors from T cells and macrophages accelerate the destabilization of atherosclerotic plaques in hyperlipidemic mice.
    Jung IH; Choi JH; Jin J; Jeong SJ; Jeon S; Lim C; Lee MR; Yoo JY; Sonn SK; Kim YH; Choi BK; Kwon BS; Seoh JY; Lee CW; Kim DY; Oh GT
    FASEB J; 2014 Nov; 28(11):4779-91. PubMed ID: 25059229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of innate and adaptive immune responses on atherosclerosis.
    Witztum JL; Lichtman AH
    Annu Rev Pathol; 2014; 9():73-102. PubMed ID: 23937439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A glimpse on the phenomenon of macrophage polarization during atherosclerosis.
    Pello OM; Silvestre C; De Pizzol M; Andrés V
    Immunobiology; 2011 Nov; 216(11):1172-6. PubMed ID: 21802768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.